Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001144204-18-052993
Filing Date
2018-10-09
Accepted
2018-10-09 16:16:11
Documents
1
Effectiveness Date
2018-10-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7139
  Complete submission text file 0001144204-18-052993.txt   8206
Mailing Address 55 MADISON STREET SUITE 400 MORRISTOWN NJ 07960
Business Address 55 MADISON STREET SUITE 400 MORRISTOWN NJ 07960 940-391-3540
Alitair Pharmaceuticals, Inc. (Filer) CIK: 0001654448 (see all company filings)

IRS No.: 272999493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-323114 | Film No.: 181113835